Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Medifast | MED | Jan 14, 2025 | 15.25 | -2.93 |
MEDIROM Healthcare Technologies ADR | MRM | Jan 14, 2025 | 1.04 | +5.56 |
MediWound | MDWD | Jan 14, 2025 | 19.02 | +3.99 |
Mednax | MD | Jan 14, 2025 | 13.66 | +2.63 |
Medpace | MEDP | Jan 14, 2025 | 330.91 | -5.99 |
Medtronic | MDT | Jan 14, 2025 | 85.25 | +4.23 |
Mega Matrix | MPU | Jan 14, 2025 | 1.15 | -4.96 |
Megacap 300 Growth Index ETF Vanguard | MGK | Jan 14, 2025 | 336.92 | -0.46 |
Megacap 300 Index ETF Vanguard | MGC | Jan 14, 2025 | 210.64 | -0.07 |
Megacap 300 Value Index ETF Vanguard | MGV | Jan 14, 2025 | 125.68 | +0.73 |
MEI Pharma | MEIP | Jan 14, 2025 | 2.75 | +1.10 |
Meihua International Medical Technologies | MHUA | Jan 14, 2025 | 0.32 | -0.25 |
MeiraGTx Holdings | MGTX | Jan 14, 2025 | 5.77 | -2.37 |
Meiwu Technology | WNW | Jan 14, 2025 | 0.95 | -68.33 |
Melar Acquisition I | MACI | Jan 14, 2025 | 10.10 | 0.00 |
Melar Acquisition I | MACIU | Jan 14, 2025 | 10.12 | 0.00 |
Melco Resorts & Entertainment ADR | MLCO | Jan 14, 2025 | 5.53 | -0.54 |
MercadoLibre | MELI | Jan 14, 2025 | 1 753.61 | +0.78 |
Mercantile Bank | MBWM | Jan 14, 2025 | 43.46 | +2.96 |
Mercer International | MERC | Jan 14, 2025 | 6.42 | +0.31 |
Merchants Bancorp | MBIN | Jan 14, 2025 | 36.01 | +1.84 |
Merchants Bancorp B | MBINO | Jan 14, 2025 | 25.00 | 0.00 |
Merchants Bancorp C Pref | MBINN | Jan 14, 2025 | 20.74 | +0.44 |
Merchants Bancorp Pref D | MBINM | Jan 14, 2025 | 26.00 | +1.01 |
Merck & Co | MRK | Jan 14, 2025 | 99.65 | -1.32 |
Mercurity Fintech | MFH | Jan 14, 2025 | 5.60 | +1.82 |
Mercury General | MCY | Jan 14, 2025 | 48.95 | +3.75 |
Mercury Systems | MRCY | Jan 14, 2025 | 43.01 | +3.02 |
Mereo BioPharma ADR | MREO | Jan 14, 2025 | 3.06 | -8.38 |
Meridian | MRBK | Jan 14, 2025 | 14.39 | +4.88 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.